Lantern Pharma Inc. (LTRN)
Company Info
Highlights
$50.04M
-$1.78
-$50.33K
-$16.31M
$2.79 - $11.99
$20.50
2.52%
1.53
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Lantern Pharma Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Lantern Pharma Inc. had a return of 45.45% year-to-date (YTD) and 16.29% in the last 12 months.
LTRN
45.45%
25.75%
4.50%
16.29%
N/A
N/A
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of LTRN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 55.17% | 45.45% | |||||||||||
| 2024 | -1.40% | 13.98% | 82.95% | -42.05% | 19.02% | -23.06% | -10.06% | -2.62% | -10.27% | -14.85% | 2.72% | -0.62% | -25.47% |
| 2023 | -0.33% | -8.80% | -12.02% | 1.45% | 6.33% | 8.25% | -17.91% | -2.38% | -24.56% | -27.27% | 59.27% | 8.35% | -29.14% |
| 2022 | -16.67% | -7.37% | 16.07% | -16.64% | -2.85% | -1.38% | -10.16% | 0.78% | -7.54% | -12.34% | 19.33% | 20.80% | -24.31% |
| 2021 | -21.92% | 18.23% | 2.08% | -17.25% | 0.73% | -3.44% | -11.64% | 9.22% | -20.65% | -8.68% | -17.34% | -5.45% | -58.55% |
| 2020 | -15.05% | -3.00% | 34.75% | 13.49% | -19.85% | 4.57% | 21.91% | 28.76% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of LTRN is 55, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Lantern Pharma Inc. (LTRN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Lantern Pharma Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Lantern Pharma Inc. was 88.69%, occurring on Oct 31, 2023. The portfolio has not yet recovered.
The current Lantern Pharma Inc. drawdown is 78.83%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -88.69% | Mar 18, 2021 | 661 | Oct 31, 2023 | — | — | — |
| -32.52% | Sep 29, 2020 | 76 | Jan 15, 2021 | 40 | Mar 16, 2021 | 116 |
| -28.43% | Jun 12, 2020 | 44 | Aug 13, 2020 | 6 | Aug 21, 2020 | 50 |
| -18.86% | Aug 26, 2020 | 8 | Sep 4, 2020 | 4 | Sep 11, 2020 | 12 |
| -16.79% | Sep 14, 2020 | 6 | Sep 21, 2020 | 5 | Sep 28, 2020 | 11 |
Volatility
Volatility Chart
The current Lantern Pharma Inc. volatility is 39.23%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Lantern Pharma Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |